Skip to main content
Top
Published in: BMC Musculoskeletal Disorders 1/2015

Open Access 01-12-2015 | Research article

A new animal model for delayed osseous union secondary to osteitis

Authors: Lars Helbig, Thorsten Guehring, Svenja Rosenberger, Adriana Ivanova, Kathrin Kaeppler, Christian Alexander Fischer, Arash Moghaddam, Gerhard Schmidmaier

Published in: BMC Musculoskeletal Disorders | Issue 1/2015

Login to get access

Abstract

Background

The treatment of infection-related delayed bone unions is still very challenging for the orthopedic surgeon. The prevalence of such infection-related types of osteitis is high in complex fractures, particularly in open fractures with extensive soft-tissue damage. The aim of this study was to develop a new animal model for delayed union due to osteitis.

Methods

After randomization to infected or non-infected groups 20 Sprague–Dawley rats underwent a transverse fracture of the midshaft tibia. After intramedullary inoculation with staphylococcus aureus (103 CFU) fracture stabilization was done by intramedullary titanium K-wires. After 5 weeks all rats were euthanized and underwent biomechanical testing to evaluate bone consolidation or delayed union, respectively. Micro-CT scans were additionally used to quantitatively evaluate the callus formation by the score of Lane and Sandhu. Blood samples were taken to analyze infectious disease markers (day 1, 14 and 35).

Results

Biomechanical testing showed a significant higher maximum torque in the non-infected group 5 weeks postoperatively compared with the infected group (p < 0.001). According to the Lane and Sandhu score a significantly higher callus formation was found in the non-infected group (p < 0.001). Similarly, the leucocyte count in the infected group was significantly higher than in the non-infected group (p < 0.05).

Conclusions

Here we have established a new animal model for delayed osseous union secondary to osteitis. The animal model appears to be appropriate for future experimental studies to test new therapeutic strategies in these difficult to treat bone healing complications.
Literature
1.
go back to reference Moghaddam A, Zimmermann G, Hammer K, Bruckner T, Grutzner PA, von Recum J. Cigarette smoking influences the clinical and occupational outcome of patients with tibial shaft fractures. Injury. 2011;42:1435–42.CrossRefPubMed Moghaddam A, Zimmermann G, Hammer K, Bruckner T, Grutzner PA, von Recum J. Cigarette smoking influences the clinical and occupational outcome of patients with tibial shaft fractures. Injury. 2011;42:1435–42.CrossRefPubMed
2.
go back to reference Heppert V, Wentzensen A. [Treatment of soft tissue damage--definitive management]. Langenbecks Archiv fur Chirurgie Supplement Kongressband Deutsche Gesellschaft fur Chirurgie Kongress. 1998;115:964–7.PubMed Heppert V, Wentzensen A. [Treatment of soft tissue damage--definitive management]. Langenbecks Archiv fur Chirurgie Supplement Kongressband Deutsche Gesellschaft fur Chirurgie Kongress. 1998;115:964–7.PubMed
3.
go back to reference Schmidt HG, Wittek F, Fink B, Buck-Gramcko U. [Treatment of chronic osteitis of the tibia]. Unfallchirurg. 1992;95:566–73.PubMed Schmidt HG, Wittek F, Fink B, Buck-Gramcko U. [Treatment of chronic osteitis of the tibia]. Unfallchirurg. 1992;95:566–73.PubMed
4.
go back to reference Lindsey BA, Clovis NB, Smith ES, Salihu S, Hubbard DF. An animal model for open femur fracture and osteomyelitis: Part I. J Orthop Res. 2010;28:38–42.PubMed Lindsey BA, Clovis NB, Smith ES, Salihu S, Hubbard DF. An animal model for open femur fracture and osteomyelitis: Part I. J Orthop Res. 2010;28:38–42.PubMed
5.
go back to reference Moghaddam A, Elleser C, Biglari B, Wentzensen A, Zimmermann G. Clinical application of BMP 7 in long bone non-unions. Arch Orthop Trauma Surg. 2010;130:71–6.CrossRefPubMed Moghaddam A, Elleser C, Biglari B, Wentzensen A, Zimmermann G. Clinical application of BMP 7 in long bone non-unions. Arch Orthop Trauma Surg. 2010;130:71–6.CrossRefPubMed
6.
go back to reference Giannoudis PV, Dinopoulos HT. Autologous bone graft: when shall we add growth factors? Orthop Clin North Am. 2010;41:85–94. table of contents.CrossRefPubMed Giannoudis PV, Dinopoulos HT. Autologous bone graft: when shall we add growth factors? Orthop Clin North Am. 2010;41:85–94. table of contents.CrossRefPubMed
7.
go back to reference Lucke M, Schmidmaier G, Sadoni S, Wildemann B, Schiller R, Stemberger A, et al. A new model of implant-related osteomyelitis in rats. J Biomed Mater Res B Appl Biomater. 2003;67:593–602.CrossRefPubMed Lucke M, Schmidmaier G, Sadoni S, Wildemann B, Schiller R, Stemberger A, et al. A new model of implant-related osteomyelitis in rats. J Biomed Mater Res B Appl Biomater. 2003;67:593–602.CrossRefPubMed
8.
go back to reference Schroeder K, Simank HG, Lorenz H, Swoboda S, Geiss HK, Helbig L. Implant stability in the treatment of MRSA bone implant infections with linezolid versus vancomycin in a rabbit model. J Orthop Res. 2012;30:190–5.CrossRefPubMed Schroeder K, Simank HG, Lorenz H, Swoboda S, Geiss HK, Helbig L. Implant stability in the treatment of MRSA bone implant infections with linezolid versus vancomycin in a rabbit model. J Orthop Res. 2012;30:190–5.CrossRefPubMed
9.
go back to reference Schmidmaier G, Wildemann B, Bail H, Lucke M, Fuchs T, Stemberger A, et al. Local application of growth factors (insulin-like growth factor-1 and transforming growth factor-beta1) from a biodegradable poly(D, L-lactide) coating of osteosynthetic implants accelerates fracture healing in rats. Bone. 2001;28:341–50.CrossRefPubMed Schmidmaier G, Wildemann B, Bail H, Lucke M, Fuchs T, Stemberger A, et al. Local application of growth factors (insulin-like growth factor-1 and transforming growth factor-beta1) from a biodegradable poly(D, L-lactide) coating of osteosynthetic implants accelerates fracture healing in rats. Bone. 2001;28:341–50.CrossRefPubMed
10.
go back to reference Bosemark P, Isaksson H, McDonald MM, Little DG. Augmentation of autologous bone graft by a combination of bone morphogenic protein and bisphosphonate increased both callus volume and strength. Acta Orthop. 2013;84:106–11.PubMedCentralCrossRefPubMed Bosemark P, Isaksson H, McDonald MM, Little DG. Augmentation of autologous bone graft by a combination of bone morphogenic protein and bisphosphonate increased both callus volume and strength. Acta Orthop. 2013;84:106–11.PubMedCentralCrossRefPubMed
11.
go back to reference Lane JM, Sandhu HS. Current approaches to experimental bone grafting. Orthop Clin North Am. 1987;18:213–25.PubMed Lane JM, Sandhu HS. Current approaches to experimental bone grafting. Orthop Clin North Am. 1987;18:213–25.PubMed
12.
go back to reference Lucke M, Wildemann B, Sadoni S, Surke C, Schiller R, Stemberger A, et al. Systemic versus local application of gentamicin in prophylaxis of implant-related osteomyelitis in a rat model. Bone. 2005;36:770–8.CrossRefPubMed Lucke M, Wildemann B, Sadoni S, Surke C, Schiller R, Stemberger A, et al. Systemic versus local application of gentamicin in prophylaxis of implant-related osteomyelitis in a rat model. Bone. 2005;36:770–8.CrossRefPubMed
13.
go back to reference Huh J, Stinner DJ, Burns TC, Hsu JR, Late Amputation Study T. Infectious complications and soft tissue injury contribute to late amputation after severe lower extremity trauma. J Trauma. 2011;71:S47–51.CrossRefPubMed Huh J, Stinner DJ, Burns TC, Hsu JR, Late Amputation Study T. Infectious complications and soft tissue injury contribute to late amputation after severe lower extremity trauma. J Trauma. 2011;71:S47–51.CrossRefPubMed
14.
go back to reference Gaston MS, Simpson AH. Inhibition of fracture healing. J Bone Joint Surg (Br). 2007;89:1553–60.CrossRef Gaston MS, Simpson AH. Inhibition of fracture healing. J Bone Joint Surg (Br). 2007;89:1553–60.CrossRef
15.
go back to reference Schmidmaier G, Lucke M, Wildemann B, Haas NP, Raschke M. Prophylaxis and treatment of implant-related infections by antibiotic-coated implants: a review. Injury. 2006;37 Suppl 2:S105–112.CrossRefPubMed Schmidmaier G, Lucke M, Wildemann B, Haas NP, Raschke M. Prophylaxis and treatment of implant-related infections by antibiotic-coated implants: a review. Injury. 2006;37 Suppl 2:S105–112.CrossRefPubMed
16.
go back to reference Zimmermann G, Wagner C, Schmeckenbecher K, Wentzensen A, Moghaddam A. Treatment of tibial shaft non-unions: bone morphogenetic proteins versus autologous bone graft. Injury. 2009;40 Suppl 3:S50–53.CrossRefPubMed Zimmermann G, Wagner C, Schmeckenbecher K, Wentzensen A, Moghaddam A. Treatment of tibial shaft non-unions: bone morphogenetic proteins versus autologous bone graft. Injury. 2009;40 Suppl 3:S50–53.CrossRefPubMed
17.
go back to reference Wagner C, Hansch GM, Wentzensen A, Heppert V. [Implant-associated post-traumatic osteomyelitis, Bacterial biofilms and the immune defence as protagonists of the local inflammatory process]. Unfallchirurg. 2006;109:761–9.CrossRefPubMed Wagner C, Hansch GM, Wentzensen A, Heppert V. [Implant-associated post-traumatic osteomyelitis, Bacterial biofilms and the immune defence as protagonists of the local inflammatory process]. Unfallchirurg. 2006;109:761–9.CrossRefPubMed
18.
go back to reference Giannoudis PV, Einhorn TA, Schmidmaier G, Marsh D. The diamond concept--open questions. Injury. 2008;39 Suppl 2:S5–8.CrossRefPubMed Giannoudis PV, Einhorn TA, Schmidmaier G, Marsh D. The diamond concept--open questions. Injury. 2008;39 Suppl 2:S5–8.CrossRefPubMed
19.
go back to reference Schmidmaier G, Lucke M, Schwabe P, Raschke M, Haas NP, Wildemann B. Collective review: bioactive implants coated with poly(D, L-lactide) and growth factors IGF-I, TGF-beta1, or BMP-2 for stimulation of fracture healing. J Long-Term Eff Med Implants. 2006;16:61–9.CrossRefPubMed Schmidmaier G, Lucke M, Schwabe P, Raschke M, Haas NP, Wildemann B. Collective review: bioactive implants coated with poly(D, L-lactide) and growth factors IGF-I, TGF-beta1, or BMP-2 for stimulation of fracture healing. J Long-Term Eff Med Implants. 2006;16:61–9.CrossRefPubMed
20.
go back to reference Schmidmaier G, Wildemann B, Bail H, Lucke M, Stemberger A, Flyvbjerg A, et al. [Local liberation of IGF-I and TGF-beta 1 from a biodegradable poly(D, L-lactide) coating of implants accelerates fracture healing]. Der Chirurg Zeitschrift fur alle Gebiete der operativen Medizen. 2000;71:1016–22.CrossRefPubMed Schmidmaier G, Wildemann B, Bail H, Lucke M, Stemberger A, Flyvbjerg A, et al. [Local liberation of IGF-I and TGF-beta 1 from a biodegradable poly(D, L-lactide) coating of implants accelerates fracture healing]. Der Chirurg Zeitschrift fur alle Gebiete der operativen Medizen. 2000;71:1016–22.CrossRefPubMed
21.
go back to reference Davis JS. Management of bone and joint infections due to Staphylococcus aureus. Intern Med J. 2005;35 Suppl 2:S79–96.CrossRefPubMed Davis JS. Management of bone and joint infections due to Staphylococcus aureus. Intern Med J. 2005;35 Suppl 2:S79–96.CrossRefPubMed
22.
go back to reference Walter G, Kemmerer M, Kappler C, Hoffmann R. Treatment algorithms for chronic osteomyelitis. Dtsch Arztebl Int. 2012;109:257–64.PubMedCentralPubMed Walter G, Kemmerer M, Kappler C, Hoffmann R. Treatment algorithms for chronic osteomyelitis. Dtsch Arztebl Int. 2012;109:257–64.PubMedCentralPubMed
23.
go back to reference Kalicke T, Schlegel U, Kraft C, Wingenfeld C, Muhr G, Arens S. [Animal models of osteomyelitis]. Orthopade. 2004;33:260–6.CrossRefPubMed Kalicke T, Schlegel U, Kraft C, Wingenfeld C, Muhr G, Arens S. [Animal models of osteomyelitis]. Orthopade. 2004;33:260–6.CrossRefPubMed
24.
go back to reference Garcia P, Histing T, Holstein JH, Klein M, Laschke MW, Matthys R, et al. Rodent animal models of delayed bone healing and non-union formation: a comprehensive review. Eur Cell Mater. 2013;26:1–12. discussion 12–14.PubMed Garcia P, Histing T, Holstein JH, Klein M, Laschke MW, Matthys R, et al. Rodent animal models of delayed bone healing and non-union formation: a comprehensive review. Eur Cell Mater. 2013;26:1–12. discussion 12–14.PubMed
25.
26.
go back to reference Chen X, Schmidt AH, Tsukayama DT, Bourgeault CA, Lew WD. Recombinant human osteogenic protein-1 induces bone formation in a chronically infected, internally stabilized segmental defect in the rat femur. J Bone Joint Surg Am. 2006;88:1510–23.CrossRefPubMed Chen X, Schmidt AH, Tsukayama DT, Bourgeault CA, Lew WD. Recombinant human osteogenic protein-1 induces bone formation in a chronically infected, internally stabilized segmental defect in the rat femur. J Bone Joint Surg Am. 2006;88:1510–23.CrossRefPubMed
27.
go back to reference Windolf CD, Logters T, Scholz M, Windolf J, Flohe S. Lysostaphin-coated titan-implants preventing localized osteitis by Staphylococcus aureus in a mouse model. PLoS One. 2014;9:e115940.PubMedCentralCrossRefPubMed Windolf CD, Logters T, Scholz M, Windolf J, Flohe S. Lysostaphin-coated titan-implants preventing localized osteitis by Staphylococcus aureus in a mouse model. PLoS One. 2014;9:e115940.PubMedCentralCrossRefPubMed
28.
go back to reference Windolf CD, Meng W, Logters TT, MacKenzie CR, Windolf J, Flohe S. Implant-associated localized osteitis in murine femur fracture by biofilm forming Staphylococcus aureus: a novel experimental model. J Orthop Res. 2013;31:2013–20.CrossRefPubMed Windolf CD, Meng W, Logters TT, MacKenzie CR, Windolf J, Flohe S. Implant-associated localized osteitis in murine femur fracture by biofilm forming Staphylococcus aureus: a novel experimental model. J Orthop Res. 2013;31:2013–20.CrossRefPubMed
29.
go back to reference Schindeler A, Yu NY, Cheng TL, Sullivan K, Mikulec K, Peacock L, et al. Local delivery of the cationic steroid antibiotic CSA-90 enables osseous union in a rat open fracture model of Staphylococcus aureus infection. J Bone Joint Surg Am. 2015;97:302–9.CrossRefPubMed Schindeler A, Yu NY, Cheng TL, Sullivan K, Mikulec K, Peacock L, et al. Local delivery of the cationic steroid antibiotic CSA-90 enables osseous union in a rat open fracture model of Staphylococcus aureus infection. J Bone Joint Surg Am. 2015;97:302–9.CrossRefPubMed
30.
go back to reference Schmidmaier G, Wildemann B, Cromme F, Kandziora F, Haas NP, Raschke M. Bone morphogenetic protein-2 coating of titanium implants increases biomechanical strength and accelerates bone remodeling in fracture treatment: a biomechanical and histological study in rats. Bone. 2002;30:816–22.CrossRefPubMed Schmidmaier G, Wildemann B, Cromme F, Kandziora F, Haas NP, Raschke M. Bone morphogenetic protein-2 coating of titanium implants increases biomechanical strength and accelerates bone remodeling in fracture treatment: a biomechanical and histological study in rats. Bone. 2002;30:816–22.CrossRefPubMed
Metadata
Title
A new animal model for delayed osseous union secondary to osteitis
Authors
Lars Helbig
Thorsten Guehring
Svenja Rosenberger
Adriana Ivanova
Kathrin Kaeppler
Christian Alexander Fischer
Arash Moghaddam
Gerhard Schmidmaier
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2015
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/s12891-015-0816-7

Other articles of this Issue 1/2015

BMC Musculoskeletal Disorders 1/2015 Go to the issue